Foot-and-Mouth disease vaccine factory now owned by Intervet
THE NETHERLANDS - Five months after signing an agreement on sale and purchase the Foot-and-Mouth (FMD) vaccine factory in Cologne Bayer HealthCare AG and Intervet International bv have completed the acquisition.
5 June 2006
2 minute read
Both parties have agreed not to disclose financial details. As of July 4, 2006 Intervet, internationally market leader in Animal Health vaccines, is responsible for managing the FMD factory. The site will become Intervet’s international competence centre for FMD vaccine production, development and research and will serve the needs from the markets for safe and efficacious FMD vaccines.
In addition to this, the factory will also engage in antigen banks, which can, under governmental contracts, guarantee emergency supply of vaccines. By acquiring the Cologne factory Intervet substantially strengthens its worldwide position in the field of Foot-and-Mouth disease vaccines.
In addition to this, the factory will also engage in antigen banks, which can, under governmental contracts, guarantee emergency supply of vaccines. By acquiring the Cologne factory Intervet substantially strengthens its worldwide position in the field of Foot-and-Mouth disease vaccines.
